English  |  正體中文  |  简体中文  |  2832485  
???header.visitor??? :  33854808    ???header.onlineuser??? :  1342
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"zhou xiaofei"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-08-08T01:17:44Z Dapl1 controls NFATc2 activation to regulate CD8+ T cell exhaustion and responses in chronic infection and cancer Zhu, Lele; Zhou, Xiaofei; Gu, Meidi; Kim, Jiseong; Li, Yanchuan; Ko, Chun-Jung; Xie, Xiaoping; Gao, Tianxiao; Cheng, Xuhong; Sun, Shao-Cong
臺大學術典藏 2022-06-14T23:23:56Z Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine Handa, Hiroshi; Cheong, June Won; Onishi, Yasushi; Iida, Hiroatsu; Kobayashi, Yukio; Kim, Hyeoung Joon; Chiou, Tzeon Jye; Izutsu, Koji; Tsukurov, Olga; Zhou, Xiaofei; Faessel, Helene; Yuan, Ying; Sedarati, Farhad; Faller, Douglas V.; Kimura, Akiko; SHANG-JU WU
國立臺灣大學 2015 Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose Venkatakrishnan, Karthik; Kim, Tae Min; Lin, Chia-Chi; Thye, Lim Soon; Chng, Wee Joo; Ma, Brigette; Chen, Ming Huang; Zhou, Xiaofei; Liu, Hua; Kelly, Virginia; Kim, Won Seog; 林家齊

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page